No Data
No Data
ASX 200 Healthcare Stock up 40% in 6 Months Halted Ahead of Major Trial Results
Neuren Pharmaceuticals Ltd (ASX: NEU) requested the trading halt before the market open today.
AU Evening Wrap: Australia Shares Rise 0.35% Amid Iron-Ore Strength
Australia shares rise 0.35% amid iron-ore strength. Fortescue, Rio Tinto and BHP added between 0.85% and 2.2%.
AU Evening Wrap: Australia Shares Fall 0.3% Ahead of Budget Announcement; Critical Minerals Miners Rise
Critical mineral miners were among the best performers on the ASX, as they were expected to be among the big winners after the budget announcement.
Brokers Name 3 ASX Shares to Buy Now 10 May 2024
It has been another busy week for Australia's top brokers. This has led to the release of a number of broker notes.
Why Cettire, De Grey Mining, Life360, and Neuren Shares Are Falling Today
The S&P/ASX 200 Index (ASX: XJO) has returned to form on Friday. In afternoon trade, the benchmark index is up 0.5% to 7,759.5 points.
Daybue Guidance Looks Achievable for Acadia, Neuren -- Market Talk
0011 GMT - Acadia Pharmaceuticals' target of $370 million-$420 million net sales of its Daybue treatment for Retts Syndrome looks achievable to Jefferies, despite a small miss in 1Q. In a research not
No Data